This study is a registry, which means it collects information from routine medical care, for patients who are prescribed blood thinners (anticoagulation) after being diagnosed with a blood clot (venous thromboembolism or VTE). This includes deep vein thrombosis (DVT) or pulmonary embolism (PE). You can join if you are 18 or older and start anticoagulation treatment within 14 days of your VTE diagnosis at the Mayo Clinic's Thrombophilia Clinic in Rochester, Minnesota. You cannot join if you are already taking blood thinners for other reasons or are in another blood thinner clinical trial. The study aims to track how often patients experience another blood clot or major bleeding over 10 years.

Study design

This is an observational study, meaning it collects information from your regular medical care without assigning specific treatments. It aims to include about 10,000 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will track outcomes like recurrent blood clots and major bleeding for up to 10 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.